News
Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback